Fresh Del Monte Produce Inc.

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Low margins
  • Strong equity
  • Q4 cash drain

AI
AI Summary

6.0

FDP's acquisition-driven pivot from a commodity grower to a branded, packaged‑food operator materially reshapes the upside—future value now hinges on successful Del Monte integration delivering measurable margin expansion and steadier, less seasonal FCF rather than commodity price recovery. Watch two actionable triggers: (1) evidence of quarter-to-quarter FCF smoothing (working‑capital/inventory turnover improvement) and (2) tangible margin gains in packaged/fresh categories; absent those, retain a hold/watch stance given banana disease exposure and impairment risk.

BrandPivot
SupplyRisk
CashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Low margins
  • Strong equity
  • Q4 cash drain

FDP trades below tangible book with healthy FY free cash flow and moderate leverage, but weak margins, large inventories/intangibles and a cash‑consuming Q4 create notable operational and cash‑flow risk.

Undervalued
MarginRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Short-term weakness
  • Below last-month average
  • High‑39s support

Over the last month FDP slipped ~3.2% to $39.83, trading ~4–4.5% below its last‑month average (~$41.7), with resistance near $42.6–$42.7 and clustered support in the high $39s (a decisive break below ~$39 would be bearish).

Constrained
Watchlist
Support Level: $39.2–$39.6
Resistance Level: $42.6–$42.7

Modest ~3.2% decline over last month rather than a sharp sell-off

Sentiment & News

6.0

Key News Insights:

  • Deal closed
  • Steady guidance
  • Active marketing

Fresh Del Monte closed a $285M deal to reunify Del Monte assets, kept modest sales and $220–$230M operating cash‑flow guidance amid banana disease pressures, and continued consumer marketing.

Acquisition
BananaRisks

The acquisition and solid cash‑flow outlook should support a positive re‑rating and near‑term stock stability, though banana disease risks could limit upside